Absci to present at global ai conference nvidia gtc

Vancouver, wash., march 16, 2022 (globe newswire) -- absci corporation (nasdaq: absi), a drug and target discovery company harnessing deep learning, ai and synthetic biology to expand the therapeutic potential of proteins, today announced that absci lead ai scientist joshua meier will be presenting at nvidia gtc .
ABSI Ratings Summary
ABSI Quant Ranking